The meta-analysis study by Chen et al. [77] revealed that high expression of metastasis associated lung adenocarcinoma transcript 1 (MALAT1) could be considered as a biomarker for diagnosis of lymph node metastasis and distant metastasis at early stages as well as a predictor of poor survival in RCC patients. Here, MALAT1 is linked to metastatic malignant neoplasm in the lymph nodes.